Key result
In male rat offspring, hypoxic pregnancy programmed cardiovascular dysfunction detectable via blood pressure and heart rate variability, with maternal MitoQ protecting against endothelial dysfunction.
Why the study?
Translating preclinical findings of pregnancy hypoxia-induced cardiovascular dysfunction to humans is challenging, requiring early in vivo diagnostic methods and protective interventions.
Does maternal treatment with MitoQ prevent programmed cardiovascular dysfunction in male offspring of hypoxic pregnancies?
Does maternal treatment with MitoQ prevent programmed cardiovascular dysfunction in male offspring of hypoxic pregnancies?
Maternal treatment with MitoQ protects against programmed endothelial dysfunction but not sympathetic hyperreactivity in offspring of hypoxic pregnancies, and these changes can be detected noninvasively via BPV and HRV.
MitoQ partially ameliorates autonomic markers in hypoxic offspring models; leaves open translation to human cardiovascular programming prevention.
Work in preclinical animal models has established that pregnancy complicated by chronic fetal hypoxia and oxidative stress programmes cardiovascular dysfunction in adult offspring. Translating this to the human condition comes with challenges, including the early diagnosis of affected individuals to improve clinical outcomes. We hypothesize that components of programmed cardiovascular dysfunction in offspring can be identified in vivo via analysis of blood pressure variability and heart rate variability and that maternal treatment with the mitochondria-targeted antioxidant MitoQ is protective. Pregnant rats were exposed to normoxia or hypoxia (13% O 2 ) ±MitoQ (500 μM in water), from 6 to 20 days gestation. Offspring were maintained in normoxia postnatally. At 16 weeks of age, 1 male per litter was instrumented with vascular catheters and a femoral blood flow probe under isoflurane anesthesia. After recovery, arterial blood pressure and femoral flow were recorded in conscious, free-moving rats and analyzed. Offspring of hypoxic pregnancy had (1) increased very-low-frequency blood pressure variability (A) and heart rate variability (B), indices consistent with impaired endothelial function and (2) increased heart rate variability low/high-frequency ratio (C) and low-frequency blood pressure variability (D), indices of cardiac and vascular sympathetic hyperreactivity, respectively. MitoQ ameliorated A and B but not C and D. We show that asymptomatic cardiovascular dysfunction in adult offspring programmed by hypoxic pregnancy can be diagnosed in vivo by blood pressure variability and heart rate variability, suggesting that these noninvasive biomarkers could be translated to the clinical setting. MitoQ protected against programmed endothelial dysfunction but not sympathetic hyperreactivity, highlighting the divergent programming mechanisms involved.
No takes yet. Share an insight, caveat, or question.
A 2021 study studied Cardiovascular dysfunction programmed by hypoxic pregnancy. Hypoxia ±MitoQ vs. Normoxia was evaluated on Blood pressure variability and heart rate variability. In male rat offspring, hypoxic pregnancy programmed cardiovascular dysfunction detectable via blood pressure and heart rate variability, with maternal MitoQ protecting against endothelial dysfunction.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: